CLARITY IN
CANCER CARE
Meet our first product: Qualyscan. Our all-in-one solution for mastering quality control in Proton Therapy Technology.
Next generation imaging technology bringing nuclear and precision medicine to the next level
Terapet SA, is a Geneva-based CERN MedTech spin-off, that has developed an innovative platform technology for imaging in nuclear medicine, bringing proton therapy and nuclear imaging to the next level.
Next Generation Imaging Technology
Terapet’s mission is to develop an innovative platform technology with integrated solutions for imaging in nuclear medicine, bringing proton therapy, nuclear imaging and precision medicine to the next level.
Terapet envisions that its Qualyscan™ and Claryscan™ will enable QUALITY and CLARITY in every patient’s diagnostic and treatment, making them the first choice for radiotherapy and precision medicine in the near future.
